Skip to main content
Heliyon logoLink to Heliyon
. 2023 Apr 17;9(4):e15525. doi: 10.1016/j.heliyon.2023.e15525

Cross-talk between the HPA axis and addiction-related regions in stressful situations

Marjan Nikbakhtzadeh a,1, Hoda Ranjbar b,1, Khadijeh Moradbeygi c, Elham Zahedi a, Mahnaz Bayat d, Monavareh Soti b,∗∗, Mohammad Shabani b,
PMCID: PMC10161713  PMID: 37151697

Abstract

Addiction is a worldwide problem that has a negative impact on society by imposing significant costs on health care, public security, and the deactivation of the community economic cycle. Stress is an important risk factor in the development of addiction and relapse vulnerability. Here we review studies that have demonstrated the diverse roles of stress in addiction. Term searches were conducted manually in important reference journals as well as in the Google Scholar and PubMed databases, between 2010 and 2022. In each section of this narrative review, an effort has been made to use pertinent sources. First, we will provide an overview of changes in the Hypothalamus-Pituitary-Adrenal (HPA) axis component following stress, which impact reward-related regions including the ventral tegmental area (VTA) and nucleus accumbens (NAc). Then we will focus on internal factors altered by stress and their effects on drug addiction vulnerability. We conclude that alterations in neuro-inflammatory, neurotrophic, and neurotransmitter factors following stress pathways can impact related mechanisms on craving and relapse susceptibility.

Keywords: Addiction, Drug abuse, HPA axis, Stress, Neuro-inflammatory, Neurotrophic, Neurotransmitter

Highlights

  • Stress is an important risk factor in the development of addiction and relapse vulnerability.

  • There is a cross-talk between the HPA axis and addiction-related regions in stressful situations.

  • Changing in the reward system, especially in response to stress, may result in drug-seeking behaviors.

  • The reward system's neurotransmitters are altered by stress and addiction.

  • Alterations in neurotransmitters following stress impact related mechanisms on craving.

1. Introduction

“Stress” is defined as the perception, evaluation, and response to harmful, threatening, or challenging events, and stressors can be either emotionally or physiologically based [1]. The stressful situation is inherent to human life, and the high level of stress is a major factor in starting the use of drugs that threaten the quality of life [2]. During stress, our body tries to regain its homeostasis and stability, which have become disrupted [3]. The hypothalamic-pituitary-adrenocortical (HPA) axis activates in response to stressors, causing glucocorticoids (GCs) (cortisol in humans, corticosterone (CORT) in rodents) to be released. Stress and GCs could elevate dopamine (DA) synthesis as a major neurotransmitter in the reward circuit [4]. As a result, the reward circuit, which is formed from neuronal connections including the prefrontal cortex (PFC), nucleus accumbens (NAc), ventral tegmental area (VTA), and amygdala, will be involved in drug reward reinstatement [5].

The effects of different types of stress, such as post-traumatic stress disorder (PTSD), pre-natal and post-natal stress, predator stress, and social deficit stress, on addiction have been evaluated in previous animal studies [6].

Furthermore, neuro-inflammatory and neurotrophic factors, as well as neurotransmitters, are also affected by addiction. In addition to being an indicator of internal stress, the HPA axis correlates with these factors that affect addiction. As a result, the goal of this study is to investigate the relationship between the HPA axis and addiction in order to determine how stress-induced changes in internal factors influence addiction vulnerability.

2. Rewarding behavior

Since reward motivates behavior and is necessary for survival, there is tremendous evolutionary pressure to remember the context of rewarding stimuli. This urge can be excessively strong, as in addiction, or weak, as in depression, which has anhedonia as a significant symptom (lack of pleasure in response to rewarding stimuli) [7]. Foraging and other behaviors that are motivated by rewards often involve a series of acts that start with a reward-seeking phase and end with an effort to retrieve and consume any rewards that were obtained during this activity [8].

3. Cores of reward circuit: the substrate for stress factors and drug abuse

The reward system origins in the medial forebrain bundle's anterior bed nuclei (glutamatergic), descends to the VTA (dopaminergic), and then ascends to the NAc (GABAergic) and PFC. Addictive drugs can directly or indirectly alter the reward system's function. In a bidirectional way, addiction may be caused by dysregulation of the reward system [9] by stress, which will be discussed below. In this review, our focus is more on the VTA and NAc areas.

4. The reward system's neurotransmitters are altered by stress and addiction

4.1. Dopamine

Stress-induced DA release in the NAc, which is facilitated by GCs. A number of mechanisms could account for the GCs' facilitation of DA release. 1) GCs increase DA synthesis through tyrosine hydroxylase (TH). 2) Monoamine-oxydase (MAO) is decreased by GCs. 3) GCs decrease DA reuptake. 4) GCs may also be able to influence extracellular DA via a number of neurotransmitters, including glutamate, opioids, GABA, and serotonin (5-HT). 5) GCs alter the dopaminergic neurons' rate of firing [10].

Several studies have shown that addictive drugs increase extracellular DA preferentially in the NAc in rats, non-human primates, and humans. Studies that have been done on self-administration (a type of operant training in which rats change their behavior and become addicts by receiving drugs as rewards) in local intracerebral areas have also confirmed that the NAc shell is the most sensitive location for DA-dependent rewards. Because of this, the NAc shell is the primary substrate for the dopaminergic terminal affected by acute exposure to addictive drugs in a naive individual. The bed nucleus of stria terminalis (BNST), which belongs to the extended amygdala and shares some anatomical similarities with the NAc, is also another sensitive area [11]. CRF (Corticotrophin-releasing factor)-R1 activation in the BNST is required for stress-induced cocaine-seeking relapse [12]. BNST sends CRF projections to the VTA that also co-release CRF. Glutamatergic and GABAergic projections from the BNST to the VTA have also been described [13].

Psychostimulants, by acting on the axonal terminal regions, increases DA release or inhibit its reuptake, leading to enhancement of the extracellular DA, while ethanol increase DA release by stimulating the firing activity of VTA DA neurons [14]. It has been suggested that tonic versus phasic DA releases mediate distinct aspects of addiction. Changes in burst firing may contribute to reward-specific information transmission, while changes in tonic firing are related to other aspects of addiction, such as withdrawal and craving. The excitatory effect of ethanol on VTA DA firing results in sustained increases in their tonic/burst firing, or both [15] (Table .1). While addictive drugs produce immediate increases in DA release during acute exposure, they also produce persistent changes in DA release during abstinence from the drug. Therefore, prolonged alterations in the firing activity of VTA DA neurons are noteworthy in this regard [16].

Table 1.

Overview of neurotransmitters alteration following stress and addiction in the reward system.

DA GABA Glu AEA NE 5-HT Orexin
Chronic stress VTA _
NAc
Addiction VTA _
NAc

4.2. GABA

VTA GABA neurons, in general, provide local inhibition of VTA DA neurons. VTA GABA neurons, as a mediator of reward and aversion, are also involved in addiction, depression, and other stress-related disorders [17]. For instance, opioids hyperpolarized the VTA GABA neurons and disinhibited the VTA DA neurons [18].

CRF enhances the firing rate of dopaminergic and GABAergic neurons in the VTA [19]. Jennings et al. have illustrated that the footshock or a footshock-associated cue attenuated the firing rate of GABAergic neurons in the VTA, which transmit to the GABA neurons of the BNST. GABA afferents of BNST can inhibit the VTA GABAergic neurons and disinhibit the VTA DA neurons [20], while in an acute footshock stress situation, the BNST glutamatergic neurons showed an increment in firing rate, excited the VTA GABA neurons, and suppressed the dopaminergic firing rate [17]. As shown in acute stress, which increases the firing of VTA GABA neurons almost immediately, its lasting effects are more complicated because the plasticity of GABAergic synapses onto dopaminergic neurons is affected over a longer period of time. The GABAergic plasticity is thus lost over the following days, which removes the inhibitory effect of GABA on VTA DA firing [17].

Chronic unpredictable mild stress (CUMS)-induced depression results in a decrease in inhibitory synapse outputs, excitability, and excitatory synaptic reception in the NAc. Because the NAc contains GABAergic neurons, all of these attenuated changes in the subcellular compartments of GABAergic neurons result in the dysfunction of the NAc during chronic stress, which leads to major depression [21].

The basal level of extracellular GABA in the NAc increases 3 weeks after discontinuing treatment with cocaine injections [22]. Additionally, there is evidence for reciprocal presynaptic modulation between GABA, DA, and glutamate in the NAc, implicating altered GABA transmission in mediating the cocaine-induced changes to DA and glutamate transmission [23] (Table .1). Based on the above-mentioned studies, we can conclude that stress decreases the level of GABA in both the VTA and NAc, which are reversed by addiction (Fig. 1A and B). Therefore, drug-seeking behavior may also be influenced by changes in GABA levels, that needs further investigation.

Fig. 1.

Fig. 1

A schematic diagram of the brain reward circuit involved in addiction. The hippocampus, PFC, NAc, and amygdala receive projections from the VTA. In all reward and stress regions, GRs are present. A) As a result of the interaction between stress and the reward system, the LH-orexin neurons modulate the VTA DA neurons. VTA receives projections from BNST. PFC glutamatergic neurons communicate with VTA, DA, and NAc neurons. NAc, the hippocampus, and the BNST are modulated by glutamatergic neurons in the amygdala. NAc receives glutamatergic projections from the hippocampus. VTA and NAc receive serotonergic and norepinephrine projections from DRN and LC. B) The alteration of the reward system following addiction. The serotonergic pathways from DRN/LC to VTA and NAc are increased. The NE is also increased in the NAc. The GABA pathway from NAc to VTA was increased, as was the LH-oexin pathway to VTA. The thick arrow depicts hyperactivity, while the thin arrow depicts hypoactivity. Created with BioRender.com.

4.3. Glutamate

Previous research has looked at other stress-induced changes in VTA DA neurons after drug abuse, such as hyperexcitability [24,25], upregulation of AMPAR subunit glutamate receptor 1 (GluR1), and NMDAR1 subunit. Acute swim stress increases the AMPA/NMDA ratio of excitatory synapses as much as drug abuse, which has a similar impact on VTA DA neurons [26,27], which requires GRs, glutamate A1 receptor (GluRA1), and NMDARs activation [26,27]. Western blot data showed social stress-induced cocaine cross-sensitization via augmentation of the VTA GluRA1 content [28]. Injections of CRF-receptor-2 (CRFR2) antagonists, but not CRFR1 antagonists, in the VTA area reduced glutamate and DA release and mitigated drug relapse [29].

The dopaminergic system is believed to mediate compulsive drug use at the level of the NAc; in contrast, the glutamatergic system's activity at the level of the NAc is mostly responsible for relapse after drug extinction [30]. Following stress, synaptic changes in the NAc shell reflect an enhancement of AMPAR-mediated currents but not of NMDAR miniature EPSCs. Stress-induced reinstatement of drug-seeking behavior in animals and relapse in humans may be related to altered processing of information via the plasticity of excitatory inputs [31]. Another study found that stress-induced glutamate-dependent DA enhancements in the NAc core which leads to the vulnerability to drug abuse [32]. Enhancement of glutamate release induced by conditioned cues and drug exposure in the NAc engages synaptic plasticity responsible for drug-seeking behavior [33] (Table .1). Overall, it is recognized that stress increases the expression of GluR1 and AMPA receptors in the VTA and NAc, which increases drug craving (Fig. 1).

5. The HPA axis and addiction

Stress is a physiological reaction to a physical or physiological threat [1]. In a stressful situation, stress signals from different regions such as the PFC, amygdala, and hippocampus are projected to the parvocellular neurons in the paraventricular nucleus (PVN) of the hypothalamus [34].

CRF stimulates adrenocorticotrophin (ACTH) hormone from the anterior pituitary, which subsequently triggers the secretion of cortisol/CORT from the adrenal glands. In chronic stress, the HPA axis is highly activated, and GCs released abnormally from the adrenal glands [35]. Cross-talk between the stress system and addiction at the three levels of the HPA axis has been reported in previous studies [36].

5.1. The pituitary gland, ACTH and addiction

The Pro-opiomelanocortin (POMC) system, ACTH, and β-endorphin modulate reward circuits in the brain and are involved in addictive behavior [37,38]. Smokers exposed to stress within four weeks of their relapse history had lower levels of ACTH, β-endorphin, and cortisol [31]. The β-endorphin level increased after alcohol consumption in the acute stage, but the negative feedback of cortisol on β-endorphine reduced the β-endorphine amount in the long term. ACTH is the product of β-endorphine cleavage. As a result, the reduction in ACTH was followed by a decrease in β-endorphins [38]. Chronic stress also increased the activity of the -melanocyte-stimulating hormone (-MSH) and melanocortin-4 receptor (MC4R), which resulted in a decrease in excitatory dopaminergic synapses on DA receptor type 1 (D1R)-expressing neurons in the NAc and the development of anhedonia [37].

5.2. The adrenal gland, glucocorticoids and addiction

At the third level, GCs play an important role in arousal, cognition, mood, immunity, and inflammatory reactions [39]. Moreover, studies have shown that there is a common pathway between self-administration of drugs and the release of GCs in an acute stressful situation [35]. Preclinical studies have revealed that the GCs antagonists administration in the basolateral amygdala (BLA) prevents stress-induced drug relapse [40]. Glococorticoid receptors (GRs) are expressed in the hippocampal formation, PFC, amygdala, and NAc, which are related to neural plasticity in drug abusers [[41], [42], [43]]. GRs in the NAc region play an important role in drug relapse in stressful situations by reducing DA clearance in this region [43]. In mice with knocked-out GRs genes, a reduction in firing of the VTA DA neuron and cocaine self-administration were observed [44].

The GRs of the hippocampus have a role in spatial memory formation that is induced by the Ca2+/calmodulin-dependent protein kinase II (CaMKII) and brain-derived neurotrophic factor (BDNF)-cAMP response element-binding protein (CREB) pathway [45]. Both drug abuse and GCs could have been inducing LTP in the ventral hippocampus, which relates to stress and emotional processing [46,47]. Additionally, Koenig and Olive demonstrated that GCs synthesis were blocked prior to ethanol consumption, which prevented further consumption [48]. It is clear from the aforementioned lines that stress is linked to increased HPA activity and GCs release. Therefore, GCs have a role in drug-related learning and memory [49] and also have a reciprocal relationship with drug susceptibility in drug consumers [50,51]. Below, we have discussed how certain types of drug addiction and the HPA axis are related.

6. HPA axis and alcohol addiction

It has been demonstrated that stress increases the probability of alcohol seeking in both healthy and addicted people [52]. Acute alcohol exposure whether supplied voluntarily or by an experimenter stimulated the production of CORT and ACTH, while prolonged treatment sufficient to cause dependency resulted in a dampened neuroendocrine state [53]. In people with severe alcohol use problems, protracted withdrawal and high levels of arousal can lead to HPA axis, GCs, and PFC dysfunction (AUDs). According to research, the HPA axis may be dysfunctional with binge/heavy drinking, and this is linked to non-dependent people's drive to drink [54]. Maternal separation stress (MS) mice showed a notable predilection for ethanol even at low dosages (0.1–1%), according to research on ethanol drinking behavior [55].

7. HPA axis and nicotin addiction

Stress makes it more difficult to resist the urge to use or seek out nicotine and intensifies the satisfaction that follows consumption [9]. Additionally, it has been discovered that human participants frequently attribute their prolonged nicotine abuse to stress [56]. During nicotine withdrawal, anxiety-like behavior and dysphoria (a negative and unpleasant affective state) are also connected to CRF [57]. Following long-term nicotine usage, abrupt withdrawal led to the HPA axis' hyperactivity [58].

8. HPA axis and opioid addiction

The group with maternal deprivation (MD) exhibited a greater level of CORT. In all of the brain regions, including the hippocampus and the NAc, MD rats' expression of the BDNF and GR genes was shown to have significantly decreased. Additionally, MD rats showed a substantial increase in the expression of the opioid receptor in all of the brain regions. According to previous findings, MD causes changes in the way the HPA axis works, the amount of BDNF in the body, and the opioid receptor system that make people more susceptible to morphine as adults [59]. Research on lab animals has linked the development of opiate self-administration behaviors and the progression to opiate dependency to the deregulation of numerous brain stress-responsive systems and the HPA axis [60,61]. Following the expression of conditioned place aversion (CPA), CORT levels rose. Prior to naloxone, pre-treatment with the selective CRFR1 antagonist CP-154,526 reduced the extinction duration and inhibited morphine-withdrawal-induced unpleasant memory consolidation [62].

9. VTA: stress and addiction

Dopaminergic neurons, which make up 65% of the VTA, are part of the reward prediction [17]. Recent studies revealed that CRFR1 and CRFR2 are important in the VTA response to social stress [63], and later cocaine “binge” self-administration was facilitated by these receptors’ existence [64]. Intermittent stressors have a lot of effects on different dimensions of substance consumption, which are mediated via VTA DA system activation, like psychomotor stimulant sensitization, conditioned place preference (CPP) enhancement, augmentation of cocaine self-administration, amphetamine, heroin, and cocaine seeking relapse [65].

The activity of VTA DA neurons participates in cognition, motivation, and locomotor activity, and it is widely implicated in reward-seeking such as drug abuse, and brain self-stimulation [66]. Morphine and ethanol have a reinforcing effect on VTA DA neurons by activating μ-opioid receptors [67,68]. It has been shown that VTA DA neuronal activity decreases in withdrawn rats after chronic morphine exposure [69] or ethanol administration [70].

10. NAc: stress and addiction

VTA sends the DA projections to NAc [71], which is another critical region of the reward circuit. The NAc as a major part of the ventral striatum is composed of GABAergic medium spiny neurons (MSNs) [72] which play an important role in responding to rewarding or aversive stimuli [73]. MSNs in the medial NAc shell inhibit the medial VTA DA neuron, whereas the lateral NAc shell neurons inhibit the VTA GABAergic interneurons and disinhibit the DA neurons. Hence, in a reverse direction, the DA neurons return to lateral NAc shell neurons and activate D1Rs [74]. D1R-MSNs in NAc convey reward signals, while D2R-MSNs encode aversion [75]. Drug consumption for a long time or exposure to chronic social defeat stress play an important role in the plasticity of MSN neurons in NAc, which is mediated via upregulating the D1Rs on MSN neurons and downregulating the D2Rs of these neurons in resilient animals [76]. Changes in NAc caused by stress can stimulate drug-seeking behavior as well as synaptic changes in the level of VTA projection and the lateral NAc shell [77]. Prenatal stress increased D2Rs expression in adult offspring's NAc; however, D2Rs were reduced in rats given nicotine, indicating that stress increased vulnerability to nicotine addiction [78]. In addition, restraint stress increased the response to drugs by increasing DA release in the NAc core [32]. Collectively, changing the reward system, especially in response to stress, may result in drug-seeking behaviors (Fig. 1).

11. The indirect effect of other neurotransmitters system following stress leading to addiction vulnerability

11.1. Endocannabinoid system

The endocannabinoid system (ECS) as a neuromodulatory system has a role in CNS development, synaptic plasticity, and the response to endogenous and exogenous threatening factors [79]. ECS presence in corticolimbic structures like the PFC, amygdala, and hippocampus has an important role in stress and anxiety-like behavior in adults and exerts this effect by regulating the HPA axis [80]. In a normal state, the HPA axis activity is constrained by the basal level of anandamide (AEA) in the BLA, but during stressful situations, CRF signaling coordinates a breakdown of tonic AEA activity to encourage a state of anxiety. When the effect of ECS has vanished, the HPA axis escapes constraint and GCs concentration increases [81]. AEA is an endogenous ECS that is synthesized and released by postsynaptic terminals, activates cannabinoid receptor type 1 (CB1Rs) in presynaptic terminals, and suppresses presynaptic neurotransmitter release [82].

Stress has different effects on the ECS depending on the brain region and duration of exposure. Both acute and chronic stress generally cause a reduction in the content of AEA in the brain tissue [83]. Maternal separation disrupts emotional memory formation and increases cannabinoid sensitivity by altering CB1R signaling [84]. CUMS could induce ECS signaling deficits in the NAc by impairing CB1Rs function [85]. Dysregulated neural plasticity, increased stress reactivity, unpleasant affective states, and cravings that fuel addiction are all caused by impaired ECS signaling [86]. Stress-induced alcohol consumption is influenced by ECS signaling, but not stress-induced relapse after quitting. Similar inconsistencies with cocaine have been discovered, where CB1R antagonistism does not prevent footshock-induced resumption of cocaine-seeking behavior under stress [87], but it has been discovered to stop the resumption of cocaine-seeking behavior brought on by swim stress [88] or by administering CRF directly [87]. Additionally, CB1R activation speeds up the VTA DA neurons' rate of firing, which thus increases drug seeking and reinforces marijuana's addictive properties [89]. Since ECS signaling was previously mentioned, it is plausible that the stress modality itself could have varied impacts on this situation's ECS signaling, with ECS signaling potentially being critical for some forms of stress-induced cocaine reinstatement.

Nicotine self-administration reduced baseline VTA dialysate oleoyl ethanolamide (OEA) levels and increased AEA release during nicotine intake [90]. Chronic ethanol exposure and traumatic stress have an impact on cannabinoid components in limbic regions [91]. It is likely that CB1R antagonists have antagonizing effects on alcohol and nicotine reward due to a diminished ability to increase NAc DA release. Blockade of CB1Rs, specifically in the VTA and NAc, reduces alcohol consumption [86] (Table .1).

11.2. Norepinephrine

Locus coeruleus (LC) is the region containing the norepinephrine (NE) neurons. In confronting the stressor, LC receives the projections from the paragigantocellularis nucleus of the brainstem, which have previously been enriched via CRF fibers from PVN, and BNST which led to the anxiety-like behavior [[92], [93], [94]]. BNST also receives projections from NE neurons of the LC [95]. Multiple kinds of adrenergic receptors are expressed on VTA DA neurons, which might mediate the interaction between VTA DA neurons and LC-NE inputs. Activation of VTA α1 and β3 adrenergic receptors reversed social avoidance behavior in previously identified susceptible mice and normalized the pathological hyperactivity of VTA→NAc DA neurons. Based on this phenomenon, it appears that the LC-NE system and the VTA→NAc reward circuit might be synaptically relayed by the adrenergic receptors α1 and β3 [96]. It was discovered that resilient mice released more NE from their LC neurons that project towards the VTA, suggesting that NE plays a role in mood regulation in the VTA [97]. Findings revealed that α2 adrenergic receptor agonists prevent stress-induced craving in human cocaine-dependent subjects. Additionally, it has been shown that β2 adrenergic receptor activation of a CRF-releasing projection from the BNST to the VTA is necessary for stress-induced cocaine use. In this regard, the findings show that β adrenergic receptor blockade in the BNST prevents footshock-induced reinstatement in rats [98].

Social isolation is associated with an increased response of DA and NE in the NAc and increased sensitivity to ethanol-mediated stimulation of NAc DA and NE release [99]. However, chronic stress can also attenuate the LC firing rate [100] (Table .1). Chronic nicotine self-administration lowered PVN NE release produced by footshock stress in rats, which could modify CRF neurons in this region and lead to stress hypersensitivity during chronic nicotine use [101]. Acute nicotine increased stress-induced increases in plasma corticosterone and epinephrine, implying that the stress-relieving effects of cigarette smoking are not mediated by a decrease in peripheral sympathetic nervous system activation [102]. CRFR1 and α2 noradrenergic receptor may have a role in the heightened anxiety-like behavior observed following acute heroin withdrawal in rats, potentially through increasing the release of NE in stress-related brain areas [103]. Psychological stress may increase cocaine-seeking behavior in chronically addicted individuals or animals, and medications that reduce NE transmission may prevent stress-induced reinstatement of usage [104]. As a result, NE alters during chronic stress, intensifying the effects of stress and contributing to increased craving (Fig. 1).

11.3. Serotonin

Serotonin (5-HT), which is released by the dorsal raphe nucleus (DRN), has an important role in psychiatric disorders [105]. The previous consumption of psychostimulants or opioids accompanied by chemical or physical stressors elevates the sensitivity of 5-HT neurons in DRN by increasing the GABAA receptors on these neurons [106]. In stressful circumstances, the CRF influences the DRN-5-HT system by modulating the serotonergic and GABAergic neuron dendrites [107]. Because the CRF impression on GABAergic neurons is more frequent, the electrophysiological studies indicated that the 5-HT neurons are inhibited indirectly by CRF and CRFR1 activity [105,106]. There is a complex regulation of DA release within reward circuitry that can be attributed to the multiplication of 5-HT receptors and their location on different neurons. 5-HT receptor subtypes exert excitatory effects on DA release in the NAc as well as discharge activity in VTA DA neurons that project to the NAc in substance abuse [105]. Serotonergic hypofunction, which is associated with dysphoric mood, can alter the susceptibility to stress-induced drug reinstatement [108]. Similarly, the CRF of the amygdala, by decreasing the 5-HT release in addicted rats, may be involved in aversion that is accompanied by drug withdrawal [105]. Stress reduces the reward responses of DRN 5-HT neurons and VTA DA neurons, resulting in anhedonia, a key symptom of depression. The negative effect of stress on reward responses suggests that some reduction in the reward responses of both 5-HT and dopaminergic neurons might underlie stress-induced anhedonia [109]. By decreasing 5-HT1B receptor stimulation, stress decreases 5-HT tone in the NAc of male mice to promote aversion and potentiate cocaine preference [110]. CRFR1 activation reduces 5-HT release and activates coping behavior in rats exposed to acute swimming stress [105]. However, when exposed to repeated swim stress, CRF aggregation impresses on CRFR2 and excites the 5-HT neurons, revealing passive coping behaviors such as avoidance, denial, self-blame, and immobility [105,111] (Table .1). As a result, low levels of 5-HT contribute to substance abuse initiation and relapse in acute stress conditions, whereas CRF increases 5-HT release from DRN neurons in chronic stress conditions [105]. Because 5-HT levels in reward circuits decrease with stress and increase with addiction, one reason for the proclivity to become addicted could be to compensate for the decrease in 5-HT (Fig. 1).

11.4. Orexin

Orexin (OX) neurons in the lateral hypothalamus (LH) secrete two neuropeptides, including OXA and OXB [112]. Evidence suggests that OXA signaling is more involved in reward seeking, whereas OXB signaling is associated with arousal and stress responses [[113], [114], [115]]. In some cases, such as chronic stress, compulsive drug craving, and chronic relapse, orexin neurons send projections to the hypothalamic stress systems, which activate CRF-containing neurons [112,116,117]. CRF stimulates orexin release in the LH, which is a factor involved in the activation and maintenance of arousal that is associated with the stress response and activates in response to cocaine, morphine, and their cues [118,119]. The LH is very important in motivating cocaine consumption by acting on the orexin factor [120]. Hyperarousal and withdrawal physical reactions observed after drug consumption increase orexin expression in LH neurons [121]. CRF terminals make direct synaptic contacts with orexin neurons, which express the CRF-R1/2. CRF and orexin have well-defined roles in drug-seeking behavior by regulating PFC-mediated addiction-like behaviors [122]. The induction of a stress-like state by orexin results in the reinstatement of cocaine seeking [123]. OXA projections into the paraventricular thalamus (PVT) induce cocaine-seeking behavior, which is perhaps promoted by CRF function in mediating stress and anxiety-like responses, which are well-known factors implicated in cocaine seeking in abstinent individuals [124]. Furthermore, the OXA antagonist reduces cocaine self-administration and stress-induced relapse [125].

The role of orexins in reward is partly explained by activating dopaminergic neurons in the VTA. Additionally, intra-VTA injections of orexin increase the levels of extracellular DA in NAc [126]. Cocaine exposure potentiates the synaptic plasticity via OXAR1 on VTA DA neurons and increases the firing rate of these neurons [127]. Orexin neurons project abundantly to the VTA and NAc and are activated by cues indicating food and drug rewards. OXA injections induce drug-seeking behaviors, suggesting that they are also involved in the reinstatement of reward-seeking behaviors [126]. In the NAc, chronic drug exposure has been found to result in long-term up-regulation of OXBR [115] (Table .1).

Based on previous studies, chronic stress often reduces the number of orexin-induced action potentials in DRN-5-HT neurons [128]. Stress reduces orexin, which, in turn, reduces 5-HT activation and leads to stress-induced drug craving. Chronic stress also leads to decreased prepro-orexin mRNA levels, reducing the number of orexin neurons in the VTA [129]. Orexin neurons also send many projections to the DRN [130]. However, recently, it has been shown that, following the stress condition, the neuropeptide S (NPS) of the brainstem also activates the LH orexinergic neurons [131]. Therefore, previous findings show that stress alters orexin secretion, which can mediate drug craving (Fig. 1).

11.5. The BDNF

BDNF is distributed in the cerebral cortex, hippocampus, amygdala, and hypothalamus [132], and it is contributing to neurogenesis and synaptic formation, neuronal differentiation, migration, and survival [133]. Early life separation stress increased the CRF and tyrosine hydroxylase (TH) in the hippocampus, NAc, and PVN, resulting in a reduction in the BDNF content in these regions in the offspring of mice [134]. By regulating the HPA axis, BDNF has an anxiety-like effect and is involved in neuroendocrine homeostasis [135].

There has been considerable interest in the effect of BDNF on reward-related neuronal circuitry. BDNF has been implicated in mediating synaptic plasticity associated with cocaine abuse as well as cocaine-induced behaviors, namely CPP, behavioral sensitization, and cocaine self-administration [136]. Cocaine exposure increases BDNF gene expression in the VTA, which has been linked to increased drug seeking [137].

Following intermittent social defeat stress and opiate consumption, μ-opioid receptors expression increased BDNF expression [138,139]. Episodic social defeat in rats with a cocaine abuse background increases the BDNF content of the VTA region [140,141]. While in continuously stressed rats, DA and BDNF content showed a reduction in the VTA that has a suppressive effect on cocaine seeking [142]. These conflicting findings may depend on the time of drug consumption, as studies showed that in the VTA, BDNF was significantly elevated after 10–15 days of withdrawal but not on withdrawal day 1 [143]. In the PFC, significant increases in BDNF expression were observed on withdrawal days 8 and 14, but not on withdrawal days 1 or 3 [144]. Therefore, cocaine administration regulates BDNF levels in a complex manner that varies depending on the addiction phase (e.g., acquisition/maintenance; early/late withdrawal).

It has been reported that the maternal separation, via decreased BDNF exon IV levels in the PFC area, leads to the increased exposure of adolescent mice to cocaine [145]. These mice showed a susceptibility to alcohol consumption in stressful situations in adulthood [134]. Chronic ethanol treatment reduced BDNF mRNA levels in mPFC, while forced swim stress (FSS) increased ethanol consumption [146]. Chronic stress inhibits BDNF signaling in the PFC, which is activated by cocaine and plays an important role in the development of cocaine side effects [147]. As a result, chronic stress and long-term drug consumption reduce BDNF, while BDNF increases following acute stress. Previous studies found that cocaine self-administration in rats induced a transient increase in BDNF in the NAc. Endogenous BDNF enhancement in the NAc subsequently reduced cocaine self-administration and attenuated relapse [148]. Thus, following stress or drug abuse, BDNF may have local-dependent alterations that are necessary to mediate or prevent cocaine-seeking behavior.

11.6. The neuro-inflammatory factors

There is a lot of evidence that chronic stress is linked to inflammatory processes, especially those that have to do with how the inflammatory cascade is controlled [149]. Stress and GCs sensitize the innate immune responses to proinflammatory cytokines [150]. Furthermore, stress can activate microglia and exert its function as an enhancer of microglial and glial mediators, contributing to the development of drug abuse [151,152]. Glial mediators include tumor necrosis factor-alpha (TNF-), interleukin 1 beta (IL-1), interleukin 6 (IL-6) and chemokines [153]. IL-1 and IL-6 stimulate the HPA axis and raise ACTH and CORT levels [154,155]. TNFα release from striatal microglia has been able to downregulate the AMPAR subunits in the striatum, a critical region for the motor and reward systems that receive glutamatergic and dopaminergic inputs [156]. It has been reported that the expression of the anti-inflammatory cytokine IL-10 in the NAc area reduces morphine-induced glial activation and prevents morphine CPP relapse in adulthood [157]. Furthermore, Ibudilast (an anti-inflammatory drug) used as a glial pro-inflammatory or TLR4 (inflammatory cytokine production initiator) antagonist reduced morphine-induced pro-inflammatory cytokine, morphine withdrawal behavior, and morphine-induced DA efflux in the NAc [158,159]. From the above lines of evidence, it can be concluded that anti-inflammatory or antagonistic inflammatory factors during stress can reduce the desire for drug abuse by affecting the reward pathway (Table .2).

Table 2.

The reciprocal effect of HPA axis and internal factors.

Internal factors Type of stress/drugs The reciprocal effect of HPA axis and internal factors Effect on addiction Ref
Cannabinoids Maternal separation in mice
CUMS in mice
Prolong alcohol and nicotine exposure
Intermittent footshock stress, CRF, and cocaine in rats
Swim stress and cocaine administration in mice
CUMS and alcohol consumption in mice
Single-prolonged stress and chronic intermittent ethanol in mice
The HPA axis increases sensitivity to cannabinoids
Stress deficits in ECS signaling in the NAc
CBR1 signaling dysfunction: increased stress responsivity
Blocking of CB1R decreased the craving behavior induced by CRF
Blocked by CB1R decreased the
stress-induced cocaine-seeking behavior
Alcohol reduced CB2R gene expression reduction, and CB2R agonist increased the alcohol consumption in stressful mice
In stressful mice that received alcohol, AEA content was diminished


Increased the alcohol and nicotine consumption
Increased the cocaine craving in acquisition phase not the reinstatement
Increased the stress-seeking behavior for cocaine relapse
Increased alcohol consumption
[84]
[85]

[87]
[88]
[160]
[91]
Norepinephrine Stressful situation in human with cocaine consumption
Footshock stress, cocaine consumption in rats
Social isolation
Footshock stress, nicotine abusing in rats
Restraint stress, heroin abusing in rats
Psychological stress, cocaine abusing
α2 receptor agonists prevented stress-induced craving in subjects
β2 receptor activated the CRF-releasing from the BNST to the VTA
Stress increased sensitivity to ethanol which is mediated the stimulation of NAc DA and NE release
Chronic nicotine self-administration: attenuated the PVN norepinephrine release
CRFR1 and α2 receptors caused the anxiety-like behavior during acute heroin withdrawal
Stress increased the cocaine-craving in chronic abuser individuals or animals, and norepinephrine antagonist reversed the stress-induced relapse
Decreased the cocaine craving
Increased the cocaine craving
Increased the alcohol craving


Increased the relapse
[98]
[161]
[99]
[162]
[103]
[104]
Serotonin Stress related to psychiatric disorders in rats
Drug abuse in rats
Forced swim stress, cocaine consumption in mice
The 5-HT neurons are inhibited indirectly by CRF and CRFR1 activity.
5-HT showed the excitatory effects on DA release in the NAc in substance abuse. The CRF decreased the 5-HT release
Stress decreased the 5-HT tone in the NAc and promoted the aversion of cocaine preference

Increased the drug abusing
Decreased the drug abusing
[106,107]
[105]
[163]
Orexin Stress and cocaine OXA induced cocaine-seeking behavior Increased the cocaine self-administration and stress-induced relapse [124]
BDNF Early life separation in mice offspring
Intermittent social defeat stress in rats
Episodic social defeated in rats
Maternal separation in mice
Chronic ethanol treatment and forced swim stress in mice
Stress reduced the BDNF content in the hippocampus, NAc, and PVN
Stress up regulated the BDNF expression in the VTA
Stress with a cocaine abuse background, increase the BDNF content of VTA
Stress decreased BDNF in the PFC
Ethanol and stress: reduced in BDNF mRNA levels of mPFC
Susceptibility to ethanol consumption and reinforcement
Increased the stress-induced substance abuse
Increased the drug sensitivity
Increased the cocaine sensitization
Increased the ethanol consumption
[134]
[138,139]
[140,142]
[145]
[146]
Neuroinflammatory Morphine administration in rats Ibudilast * and TLR4 ** mitigated the morphine-induced DA in the NAc Reduced the morphine abuse [158,159]

*An anti-inflammatory drug, ** TLR4: Toll-like receptor 4 (Inflammatory cytokine production initiator).

12. Conclusion

There is considerable evidence from preclinical and clinical studies that indicates an association between highly stressful situations and addiction vulnerability [164,165]. Stressor exposure causes long-lasting neuroendocrine and physiological changes in brain regions involved in learning, motivation, and stress-related adaptive behaviors, which are briefly discussed below as concluding remarks of points. 1) Stress increases the HPA's activity and GCs release. It also enhances drug-related learning and memory and increases the susceptibility to drug use. 2) VTA DA neuronal activity has been reduced after chronic morphine withdrawal. However, this effect has been reversed by restraint stress, which increased the DA release in the NAc core. 3) Stress seems to change the GABA content in both the VTA and NAc regions. GABA levels have decreased in NAc and increased in VTA following the stress, which is reversed by addiction. 4) ECS plays a similar role to addiction, depending on the type of stress, but they have an inhibitory effect on the HPA axis. 5) Following stress, an increase in the content of glutamate and its receptors (GluR1 and AMPARs) in the NAc, as well as an increase in the VTA DA level, can lead to drug cravings. 6) The reduction in 5-HT levels in reward circuits has been seen in stress conditions, while it has increased in addiction. 7) Chronic stress has increased the NE, which has a role in stress-related drug reinstatement. 8) CRF and orexin increments in stressful conditions increased drug-seeking behavior by influencing PFC to regulate addiction-like behaviors. 9) Endogenous BDNF elevation in the NAc subsequently reduced cocaine self-administration and attenuated relapse. 10) The anti-inflammatory cytokine IL-10 expression in the NAc area attenuated the morphine-induced glial activation and prevented the morphine CPP relapse.

The interaction of the HPA axis with other factors or neurotransmitters may open up new avenues for neuroscientists or neuropsychiatrists to discover therapeutics that can be used in addicted subjects. Furthermore, we suggest that more investigations are required to clarify the exact mechanism of stress and its interaction with each factor to affect addiction.

Ethics approval

All procedures performed in studies were in accordance with the ethical standards of the ethical committee of Kerman University of Medical Sciences (Ethical approval number: IR. KMU.REC.1397.610, Reg. No. 97001069).

Production notes

Author contribution statement

All authors listed have significantly contributed to the development and the writing of this article.

Data availability statement

Data will be made available on request.

Declaration of interest's statement

The authors declare no conflict of interest.

Contributor Information

Monavareh Soti, Email: monavare.soty@gmail.com.

Mohammad Shabani, Email: shabanimoh@yahoo.com, shabani@kmu.ac.ir.

References

  • 1.Chu B., et al. StatPearls. StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC; Treasure Island (FL: 2022. Physiology, stress reaction. [Google Scholar]
  • 2.Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann. N. Y. Acad. Sci. 2008;1141:105–130. doi: 10.1196/annals.1441.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Peters A., McEwen B.S., Friston K. Uncertainty and stress: why it causes diseases and how it is mastered by the brain. Prog. Neurobiol. 2017;156:164–188. doi: 10.1016/j.pneurobio.2017.05.004. [DOI] [PubMed] [Google Scholar]
  • 4.Becker-Krail D., McClung C. Implications of circadian rhythm and stress in addiction vulnerability. F1000Res. 2016;5:59. doi: 10.12688/f1000research.7608.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cooper S., Robison A.J., Mazei-Robison M.S. Reward circuitry in addiction. Neurotherapeutics. 2017;14(3):687–697. doi: 10.1007/s13311-017-0525-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Daskalakis N.P., et al. Noncoding RNAs: stress, glucocorticoids, and posttraumatic stress disorder. Biol. Psychiatr. 2018;83(10):849–865. doi: 10.1016/j.biopsych.2018.01.009. [DOI] [PubMed] [Google Scholar]
  • 7.LeGates T.A., et al. Reward behaviour is regulated by the strength of hippocampus-nucleus accumbens synapses. Nature. 2018;564(7735):258–262. doi: 10.1038/s41586-018-0740-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Halbout B., et al. Mesolimbic dopamine projections mediate cue-motivated reward seeking but not reward retrieval in rats. Elife. 2019;8 doi: 10.7554/eLife.43551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gardner E.L. Addiction and brain reward and antireward pathways. Adv. Psychosom. Med. 2011;30:22–60. doi: 10.1159/000324065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rougé-Pont F., et al. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 1998;10(12):3903–3907. doi: 10.1046/j.1460-9568.1998.00438.x. [DOI] [PubMed] [Google Scholar]
  • 11.Di Chiara G., Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr. Opin. Pharmacol. 2007;7(1):69–76. doi: 10.1016/j.coph.2006.11.003. [DOI] [PubMed] [Google Scholar]
  • 12.Haass-Koffler C.L., Bartlett S.E. Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity. Front. Mol. Neurosci. 2012;5:91. doi: 10.3389/fnmol.2012.00091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.!!! INVALID CITATION !!! [11].
  • 14.Clark A., Little H.J. Interactions between low concentrations of ethanol and nicotine on firing rate of ventral tegmental dopamine neurones. Drug Alcohol Depend. 2004;75(2):199–206. doi: 10.1016/j.drugalcdep.2004.03.001. [DOI] [PubMed] [Google Scholar]
  • 15.Foddai M., et al. Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychopharmacology. 2004;29(3):530–536. doi: 10.1038/sj.npp.1300326. [DOI] [PubMed] [Google Scholar]
  • 16.Lapish C.C., Seamans J.K., Chandler L.J. Glutamate-dopamine cotransmission and reward processing in addiction. Alcohol Clin. Exp. Res. 2006;30(9):1451–1465. doi: 10.1111/j.1530-0277.2006.00176.x. [DOI] [PubMed] [Google Scholar]
  • 17.Bouarab C., Thompson B., Polter A.M. VTA GABA neurons at the interface of stress and reward. Front. Neural Circ. 2019;13:78. doi: 10.3389/fncir.2019.00078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 1992;12(2):483–488. doi: 10.1523/JNEUROSCI.12-02-00483.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Korotkova T.M., et al. Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur. J. Neurosci. 2006;23(10):2677–2685. doi: 10.1111/j.1460-9568.2006.04792.x. [DOI] [PubMed] [Google Scholar]
  • 20.Jennings J.H., et al. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013;496(7444):224–228. doi: 10.1038/nature12041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zhu Z., et al. GABAergic neurons in nucleus accumbens are correlated to resilience and vulnerability to chronic stress for major depression. Oncotarget. 2017;8(22):35933–35945. doi: 10.18632/oncotarget.16411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Xi Z.X., et al. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J. Neurosci. 2003;23(8):3498–3505. doi: 10.1523/JNEUROSCI.23-08-03498.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Everitt B.J., Wolf M.E. Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 2002;22(9):3312–3320. doi: 10.1523/JNEUROSCI.22-09-03312.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Razavinasab M., et al. Hyperexcitability of VTA dopaminergic neurons in male offspring exposed to physical or psychological prenatal stress. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2020;101:109923. doi: 10.1016/j.pnpbp.2020.109923. [DOI] [PubMed] [Google Scholar]
  • 25.Hausknecht K., Haj-Dahmane S., Shen R.Y. Prenatal stress exposure increases the excitation of dopamine neurons in the ventral tegmental area and alters their reponses to psychostimulants. Neuropsychopharmacology. 2013;38(2):293–301. doi: 10.1038/npp.2012.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Saal D., et al. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003;37(4):577–582. doi: 10.1016/s0896-6273(03)00021-7. [DOI] [PubMed] [Google Scholar]
  • 27.Dong Y., et al. Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice. Proc. Natl. Acad. Sci. U. S. A. 2004;101(39):14282–14287. doi: 10.1073/pnas.0401553101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Covington H.E., 3rd, et al. NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking. Psychopharmacology (Berl) 2008;197(2):203–216. doi: 10.1007/s00213-007-1024-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wise R.A. Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction. Trends Neurosci. 2009;32(10):517–524. doi: 10.1016/j.tins.2009.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kalivas P.W., Volkow N.D. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. Psychiatr. 2011;16(10):974–986. doi: 10.1038/mp.2011.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.alʼAbsi M. Stress and addiction: when a robust stress response indicates resiliency. Psychosom. Med. 2018;80(1):2–16. doi: 10.1097/PSY.0000000000000520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pacchioni A.M., et al. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress. Neuropsychopharmacology. 2007;32(3):682–692. doi: 10.1038/sj.npp.1301080. [DOI] [PubMed] [Google Scholar]
  • 33.Scofield M.D., et al. The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol. Rev. 2016;68(3):816–871. doi: 10.1124/pr.116.012484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.!!! INVALID CITATION !!! [7, 8].
  • 35.Srinivasan S., Shariff M., Bartlett S.E. The role of the glucocorticoids in developing resilience to stress and addiction. Front. Psychiatr. 2013;4:68. doi: 10.3389/fpsyt.2013.00068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.!!! INVALID CITATION !!! [12].
  • 37.Derkach K.V., Romanova I.V., Shpakov A.O. Functional interaction between the dopamine and melanocortin systems in the brain. Ross Fiziol Zh Im I M Sechenova. 2016;102(12):1393–1405. [PubMed] [Google Scholar]
  • 38.Karin O., Raz M., Alon U. An opponent process for alcohol addiction based on changes in endocrine gland mass. iScience. 2021;24(3) doi: 10.1016/j.isci.2021.102127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Oster H., et al. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr. Rev. 2017;38(1):3–45. doi: 10.1210/er.2015-1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Taslimi Z., Sarihi A., Haghparast A. Glucocorticoid receptors in the basolateral amygdala mediated the restraint stress-induced reinstatement of methamphetamine-seeking behaviors in rats. Behav. Brain Res. 2018;348:150–159. doi: 10.1016/j.bbr.2018.04.022. [DOI] [PubMed] [Google Scholar]
  • 41.Barsegyan A., et al. Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism. Proc. Natl. Acad. Sci. U. S. A. 2010;107(38):16655–16660. doi: 10.1073/pnas.1011975107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Barsegyan A., et al. The vasopressin 1b receptor antagonist A-988315 blocks stress effects on the retrieval of object-recognition memory. Neuropsychopharmacology. 2015;40(8):1979–1989. doi: 10.1038/npp.2015.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Parnaudeau S., et al. Glucocorticoid receptor gene inactivation in dopamine-innervated areas selectively decreases behavioral responses to amphetamine. Front. Behav. Neurosci. 2014;8:35. doi: 10.3389/fnbeh.2014.00035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ambroggi F., et al. Stress and addiction: glucocorticoid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nat. Neurosci. 2009;12(3):247–249. doi: 10.1038/nn.2282. [DOI] [PubMed] [Google Scholar]
  • 45.Chen D.Y., et al. Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidation. Nat. Neurosci. 2012;15(12):1707–1714. doi: 10.1038/nn.3266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010;65(1):7–19. doi: 10.1016/j.neuron.2009.11.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Keralapurath M.M., et al. Cocaine- or stress-induced metaplasticity of LTP in the dorsal and ventral hippocampus. Hippocampus. 2014;24(5):577–590. doi: 10.1002/hipo.22250. [DOI] [PubMed] [Google Scholar]
  • 48.Koenig H.N., Olive M.F. The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Psychoneuroendocrinology. 2004;29(8):999–1003. doi: 10.1016/j.psyneuen.2003.09.004. [DOI] [PubMed] [Google Scholar]
  • 49.Goldfarb E.V., Sinha R. Drug-induced glucocorticoids and memory for substance use. Trends Neurosci. 2018;41(11):853–868. doi: 10.1016/j.tins.2018.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Sinha R., et al. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch. Gen. Psychiatr. 2006;63(3):324–331. doi: 10.1001/archpsyc.63.3.324. [DOI] [PubMed] [Google Scholar]
  • 51.Nazeri M., et al. Psychological stress has a higher rate of developing addictive behaviors compared to physical stress in rat offspring. Excli j. 2017;16:903–913. doi: 10.17179/excli2016-685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Clay J.M., Parker M.O. The role of stress-reactivity, stress-recovery and risky decision-making in psychosocial stress-induced alcohol consumption in social drinkers. Psychopharmacology (Berl) 2018;235(11):3243–3257. doi: 10.1007/s00213-018-5027-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Richardson H.N., et al. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur. J. Neurosci. 2008;28(8):1641–1653. doi: 10.1111/j.1460-9568.2008.06455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Blaine S.K., Sinha R. Alcohol, stress, and glucocorticoids: from risk to dependence and relapse in alcohol use disorders. Neuropharmacology. 2017;122:136–147. doi: 10.1016/j.neuropharm.2017.01.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Biggio F., et al. Low doses of prenatal ethanol exposure and maternal separation alter HPA axis function and ethanol consumption in adult male rats. Neuropharmacology. 2018;131:271–281. doi: 10.1016/j.neuropharm.2017.12.005. [DOI] [PubMed] [Google Scholar]
  • 56.Bruijnzeel A.W. Tobacco addiction and the dysregulation of brain stress systems. Neurosci. Biobehav. Rev. 2012;36(5):1418–1441. doi: 10.1016/j.neubiorev.2012.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Bruijnzeel A.W. Neuropeptide systems and new treatments for nicotine addiction. Psychopharmacology (Berl) 2017;234(9–10):1419–1437. doi: 10.1007/s00213-016-4513-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Bagosi Z., et al. Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice. Brain Res. 2016;1652:21–29. doi: 10.1016/j.brainres.2016.09.044. [DOI] [PubMed] [Google Scholar]
  • 59.Askari N., Mousavi A., Vaez-Mahdavi M.R. Maternal deprivation effect on morphine-induced CPP is related to changes in opioid receptors in selected rat brain regions (hippocampus, prefrontal cortex, and nucleus accumbens) Behav. Process. 2022;197:104607. doi: 10.1016/j.beproc.2022.104607. [DOI] [PubMed] [Google Scholar]
  • 60.Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatr. 2007;164(8):1149–1159. doi: 10.1176/appi.ajp.2007.05030503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Breese G.R., Sinha R., Heilig M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol. Ther. 2011;129(2):149–171. doi: 10.1016/j.pharmthera.2010.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Navarro-Zaragoza J., et al. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: role of HPA axis. Pharmacol. Biochem. Behav. 2021;201:173106. doi: 10.1016/j.pbb.2021.173106. [DOI] [PubMed] [Google Scholar]
  • 63.Holly E.N., DeBold J.F., Miczek K.A. Increased mesocorticolimbic dopamine during acute and repeated social defeat stress: modulation by corticotropin releasing factor receptors in the ventral tegmental area. Psychopharmacology (Berl) 2015;232(24):4469–4479. doi: 10.1007/s00213-015-4082-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Boyson C.O., et al. Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration. J. Neurosci. 2014;34(19):6659–6667. doi: 10.1523/JNEUROSCI.3942-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Yap J.J., Miczek K.A. Stress and rodent models of drug addiction: role of VTA-accumbens-PFC-amygdala circuit. Drug Discov. Today Dis. Model. 2008;5(4):259–270. doi: 10.1016/j.ddmod.2009.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Schultz W. Dopamine reward prediction-error signalling: a two-component response. Nat. Rev. Neurosci. 2016;17(3):183–195. doi: 10.1038/nrn.2015.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chartoff E.H., et al. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J. Neurosci. 2006;26(24):6450–6457. doi: 10.1523/JNEUROSCI.0491-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Bassareo V., et al. Inhibition of morphine- and ethanol-mediated stimulation of mesolimbic dopamine neurons by withania somnifera. Front. Neurosci. 2019;13:545. doi: 10.3389/fnins.2019.00545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Georges F., Le Moine C., Aston-Jones G. No effect of morphine on ventral tegmental dopamine neurons during withdrawal. J. Neurosci. 2006;26(21):5720–5726. doi: 10.1523/JNEUROSCI.5032-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Morikawa H., Morrisett R.A. Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. Int. Rev. Neurobiol. 2010;91:235–288. doi: 10.1016/S0074-7742(10)91008-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Gui H., et al. Dopaminergic projections from the ventral tegmental area to the nucleus accumbens modulate sevoflurane anesthesia in mice. Front. Cell. Neurosci. 2021;15:671473. doi: 10.3389/fncel.2021.671473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Klawonn A.M., Malenka R.C. Nucleus accumbens modulation in reward and aversion. Cold Spring Harbor Symp. Quant. Biol. 2019;83:119–129. doi: 10.1101/sqb.2018.83.037457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Volkow N.D., Wise R.A., Baler R. The dopamine motive system: implications for drug and food addiction. Nat. Rev. Neurosci. 2017;18(12):741–752. doi: 10.1038/nrn.2017.130. [DOI] [PubMed] [Google Scholar]
  • 74.Yang H., et al. Nucleus accumbens subnuclei regulate motivated behavior via direct inhibition and disinhibition of VTA dopamine subpopulations. Neuron. 2018;97(2):434–449.e4. doi: 10.1016/j.neuron.2017.12.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Soares-Cunha C., et al. Nucleus accumbens medium spiny neurons subtypes signal both reward and aversion. Mol. Psychiatr. 2020;25(12):3241–3255. doi: 10.1038/s41380-019-0484-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Khibnik L.A., et al. Stress and cocaine trigger divergent and cell type-specific regulation of synaptic transmission at single spines in nucleus accumbens. Biol. Psychiatr. 2016;79(11):898–905. doi: 10.1016/j.biopsych.2015.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Nelson A.B., Kreitzer A.C. Reassessing models of basal ganglia function and dysfunction. Annu. Rev. Neurosci. 2014;37:117–135. doi: 10.1146/annurev-neuro-071013-013916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Said N., et al. Prenatal stress induces vulnerability to nicotine addiction and alters D2 receptors' expression in the nucleus accumbens in adult rats. Neuroscience. 2015;304:279–285. doi: 10.1016/j.neuroscience.2015.07.029. [DOI] [PubMed] [Google Scholar]
  • 79.Cadet J.L. Epigenetics of stress, addiction, and resilience: therapeutic implications. Mol. Neurobiol. 2016;53(1):545–560. doi: 10.1007/s12035-014-9040-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Hill M.N., et al. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J. Neurosci. 2011;31(29):10506–10515. doi: 10.1523/JNEUROSCI.0496-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Gray J.M., et al. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J. Neurosci. 2015;35(9):3879–3892. doi: 10.1523/JNEUROSCI.2737-14.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Scherma M., et al. Brain activity of anandamide: a rewarding bliss? Acta Pharmacol. Sin. 2019;40(3):309–323. doi: 10.1038/s41401-018-0075-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Morena M., et al. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41(1):80–102. doi: 10.1038/npp.2015.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Martín-Sánchez A., et al. Early-life stress exacerbates the effects of WIN55,212-2 and modulates the cannabinoid receptor type 1 expression. Neuropharmacology. 2021;184:108416. doi: 10.1016/j.neuropharm.2020.108416. [DOI] [PubMed] [Google Scholar]
  • 85.Wang W., et al. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology. 2010;35(11):2249–2261. doi: 10.1038/npp.2010.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Parsons L.H., Hurd Y.L. Endocannabinoid signalling in reward and addiction. Nat. Rev. Neurosci. 2015;16(10):579–594. doi: 10.1038/nrn4004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Kupferschmidt D.A., Klas P.G., Erb S. Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization. Br. J. Pharmacol. 2012;167(1):196–206. doi: 10.1111/j.1476-5381.2012.01983.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Vaughn L.K., et al. Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience. 2012;204:117–124. doi: 10.1016/j.neuroscience.2011.08.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.French E.D., Dillon K., Wu X. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport. 1997;8(3):649–652. doi: 10.1097/00001756-199702100-00014. [DOI] [PubMed] [Google Scholar]
  • 90.Buczynski M.W., Polis I.Y., Parsons L.H. The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area. Neuropsychopharmacology. 2013;38(4):574–584. doi: 10.1038/npp.2012.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Piggott V.M., et al. Traumatic stress, chronic ethanol exposure, or the combination, alter cannabinoid system components in reward and limbic regions of the mouse brain. Molecules. 2021;26(7) doi: 10.3390/molecules26072086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.McCall J.G., et al. CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety. Neuron. 2015;87(3):605–620. doi: 10.1016/j.neuron.2015.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Pomrenze M.B., et al. Dissecting the roles of GABA and neuropeptides from rat central amygdala CRF neurons in anxiety and fear learning. Cell Rep. 2019;29(1):13–21.e4. doi: 10.1016/j.celrep.2019.08.083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Reyes B.A., et al. Hypothalamic projections to locus coeruleus neurons in rat brain. Eur. J. Neurosci. 2005;22(1):93–106. doi: 10.1111/j.1460-9568.2005.04197.x. [DOI] [PubMed] [Google Scholar]
  • 95.Aston-Jones G., Kalivas P.W. Brain norepinephrine rediscovered in addiction research. Biol. Psychiatr. 2008;63(11):1005–1006. doi: 10.1016/j.biopsych.2008.03.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Zhang H., et al. α(1)- and β(3)-adrenergic receptor-mediated mesolimbic homeostatic plasticity confers resilience to social stress in susceptible mice. Biol. Psychiatr. 2019;85(3):226–236. doi: 10.1016/j.biopsych.2018.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Isingrini E., et al. Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons. Nat. Neurosci. 2016;19(4):560–563. doi: 10.1038/nn.4245. [DOI] [PubMed] [Google Scholar]
  • 98.Mantsch J.R., et al. Neurobiological mechanisms that contribute to stress-related cocaine use. Neuropharmacology. 2014;76:383–394. doi: 10.1016/j.neuropharm.2013.07.021. Pt B(0 0) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Karkhanis A.N., et al. Social isolation rearing increases nucleus accumbens dopamine and norepinephrine responses to acute ethanol in adulthood. Alcohol Clin. Exp. Res. 2014;38(11):2770–2779. doi: 10.1111/acer.12555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Chaijale N.N., et al. Repeated social stress increases reward salience and impairs encoding of prediction by rat locus coeruleus neurons. Neuropsychopharmacology. 2015;40(2):513–523. doi: 10.1038/npp.2014.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Yu G., Sharp B.M. Nicotine self-administration diminishes stress-induced norepinephrine secretion but augments adrenergic-responsiveness in the hypothalamic paraventricular nucleus and enhances adrenocorticotropic hormone and corticosterone release. J. Neurochem. 2010;112(5):1327–1337. doi: 10.1111/j.1471-4159.2009.06551.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Morse D.E. Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress responses by the administration of nicotine. Psychopharmacology (Berl) 1989;98(4):539–543. doi: 10.1007/BF00441956. [DOI] [PubMed] [Google Scholar]
  • 103.Park P.E., et al. Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats. Int. J. Neuropsychopharmacol. 2013;16(8):1867–1875. doi: 10.1017/S1461145713000308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Fitzgerald P.J. Elevated norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: alcohol, nicotine, marijuana, heroin, cocaine, and caffeine. Subst. Abuse. 2013;7:171–183. doi: 10.4137/SART.S13019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Valentino R.J., Lucki I., Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res. 2010;1314:29–37. doi: 10.1016/j.brainres.2009.09.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Kirby L.G., et al. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 2008;28(48):12927–12937. doi: 10.1523/JNEUROSCI.2887-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Waselus M., Valentino R.J., Van Bockstaele E.J. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotropin-releasing factor on the rat dorsal raphe serotonin system. J. Comp. Neurol. 2005;482(2):155–165. doi: 10.1002/cne.20360. [DOI] [PubMed] [Google Scholar]
  • 108.Li C., Kirby L.G. Effects of cocaine history on postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats. Eur. Neuropsychopharmacol. 2016;26(1):45–54. doi: 10.1016/j.euroneuro.2015.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Zhong W., et al. 2017. Learning and Stress Shape the Reward Response Patterns of Serotonin Neurons; pp. 8863–8875. 37(37) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Fontaine H.M., et al. 2022. Stress Decreases Serotonin Tone in the Nucleus Accumbens in Male Mice to Promote Aversion and Potentiate Cocaine Preference via Decreased Stimulation of 5-HT(1B) Receptors; pp. 891–901. 47(4) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Price M.L., et al. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology (Berl) 2002;162(4):406–414. doi: 10.1007/s00213-002-1114-2. [DOI] [PubMed] [Google Scholar]
  • 112.Giardino W.J., de Lecea L. Hypocretin (orexin) neuromodulation of stress and reward pathways. Curr. Opin. Neurobiol. 2014;29:103–108. doi: 10.1016/j.conb.2014.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Georgescu D., et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 2003;23(8):3106–3111. doi: 10.1523/JNEUROSCI.23-08-03106.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Boutrel B., Cannella N., de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res. 2010;1314:103–111. doi: 10.1016/j.brainres.2009.11.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Qi K., et al. Orexin receptors within the nucleus accumbens shell mediate the stress but not drug priming-induced reinstatement of morphine conditioned place preference. Front. Behav. Neurosci. 2013;7:144. doi: 10.3389/fnbeh.2013.00144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Schmitt O., et al. Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct. Funct. 2012;217(2):233–256. doi: 10.1007/s00429-011-0343-8. [DOI] [PubMed] [Google Scholar]
  • 117.Ciriello J., et al. Identification of neurons containing orexin-B (hypocretin-2) immunoreactivity in limbic structures. Brain Res. 2003;967(1–2):123–131. doi: 10.1016/s0006-8993(02)04233-6. [DOI] [PubMed] [Google Scholar]
  • 118.Pañeda C., et al. The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction. Drug News Perspect. 2005;18(4):250–255. doi: 10.1358/dnp.2005.18.4.908659. [DOI] [PubMed] [Google Scholar]
  • 119.Aston-Jones G., et al. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology. 2009;56(Suppl 1):112–121. doi: 10.1016/j.neuropharm.2008.06.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Mahler S.V., et al. Multiple roles for orexin/hypocretin in addiction. Prog. Brain Res. 2012;198:79–121. doi: 10.1016/B978-0-444-59489-1.00007-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Laorden M.L., et al. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One. 2012;7(5) doi: 10.1371/journal.pone.0036871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Perry C.J., Cornish J.L.J.A.N. vol. 2. 2022. pp. 1–10. (Four Hypothalamic Peptides and Their Impact on Drug-Seeking Behaviour: a Prefrontal Cortex View). [Google Scholar]
  • 123.Boutrel B., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U. S. A. 2005;102(52):19168–19173. doi: 10.1073/pnas.0507480102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Matzeu A., et al. Orexin-A/Hypocretin-1 mediates cocaine-seeking behavior in the posterior paraventricular nucleus of the thalamus via orexin/hypocretin receptor-2. J. Pharmacol. Exp. Therapeut. 2016;359(2):273–279. doi: 10.1124/jpet.116.235945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Brooks S., et al. The selective orexin-2 receptor antagonist seltorexant improves sleep: an exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia. J. Psychopharmacol. 2019;33(2):202–209. doi: 10.1177/0269881118822258. [DOI] [PubMed] [Google Scholar]
  • 126.España R.A., et al. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 2011;214(2):415–426. doi: 10.1007/s00213-010-2048-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Baimel C., Borgland S.L. Hypocretin modulation of drug-induced synaptic plasticity. Prog. Brain Res. 2012;198:123–131. doi: 10.1016/B978-0-444-59489-1.00008-2. [DOI] [PubMed] [Google Scholar]
  • 128.Sargin D., Oliver D.K. 2016. Chronic Social Isolation Reduces 5-HT Neuronal Activity via Upregulated SK3 Calcium-Activated Potassium Channels; p. 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Nocjar C., et al. The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus. Neuroscience. 2012;218:138–153. doi: 10.1016/j.neuroscience.2012.05.033. [DOI] [PubMed] [Google Scholar]
  • 130.Lee H.S., et al. Retrograde study of hypocretin-1 (orexin-A) projections to subdivisions of the dorsal raphe nucleus in the rat. Brain Res. 2005;1059(1):35–45. doi: 10.1016/j.brainres.2005.08.016. [DOI] [PubMed] [Google Scholar]
  • 131.Tobinski A.M., Rappeneau V. Role of the neuropeptide S system in emotionality, stress responsiveness and addiction-like behaviours in rodents: relevance to stress-related disorders. Pharmaceuticals. 2021;14(8) doi: 10.3390/ph14080780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Pruunsild P., et al. Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics. 2007;90(3):397–406. doi: 10.1016/j.ygeno.2007.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Baydyuk M., Xu B. BDNF signaling and survival of striatal neurons. Front. Cell. Neurosci. 2014;8:254. doi: 10.3389/fncel.2014.00254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Garcia-Gutierrez M.S., et al. Increased vulnerability to ethanol consumption in adolescent maternal separated mice. Addiction Biol. 2016;21(4):847–858. doi: 10.1111/adb.12266. [DOI] [PubMed] [Google Scholar]
  • 135.Kozlovsky N., et al. Microinfusion of a corticotrophin-releasing hormone receptor 1 antisense oligodeoxynucleotide into the dorsal hippocampus attenuates stress responses at specific times after stress exposure. J. Neuroendocrinol. 2012;24(3):489–503. doi: 10.1111/j.1365-2826.2011.02267.x. [DOI] [PubMed] [Google Scholar]
  • 136.Li X., Wolf M.E. Multiple faces of BDNF in cocaine addiction. Behav. Brain Res. 2015;279:240–254. doi: 10.1016/j.bbr.2014.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.McCarthy D.M., Brown A.N., Bhide P.G. Regulation of BDNF expression by cocaine. Yale J. Biol. Med. 2012;85(4):437–446. [PMC free article] [PubMed] [Google Scholar]
  • 138.Johnston C.E., et al. Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor. Neuropharmacology. 2015;89:325–334. doi: 10.1016/j.neuropharm.2014.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Ting A.K.R., et al. Ventral tegmental area GABA neurons and opiate motivation. Psychopharmacology (Berl) 2013;227(4):697–709. doi: 10.1007/s00213-013-3002-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Miczek K.A., et al. Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats. J. Neurosci. 2011;31(27):9848–9857. doi: 10.1523/JNEUROSCI.0637-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Wang J., et al. BDNF overexpression in the ventral tegmental area prolongs social defeat stress-induced cross-sensitization to amphetamine and increases DeltaFosB expression in mesocorticolimbic regions of rats. Neuropsychopharmacology. 2013;38(11):2286–2296. doi: 10.1038/npp.2013.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Wang J., et al. BDNF overexpression in the ventral tegmental area prolongs social defeat stress-induced cross-sensitization to amphetamine and increases ΔFosB expression in mesocorticolimbic regions of rats. Neuropsychopharmacology. 2013;38(11):2286–2296. doi: 10.1038/npp.2013.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143.Pu L., Liu Q.S., Poo M.M. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci. 2006;9(5):605–607. doi: 10.1038/nn1687. [DOI] [PubMed] [Google Scholar]
  • 144.Lu H., et al. Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition. Neuron. 2010;67(5):821–833. doi: 10.1016/j.neuron.2010.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Viola T.W., et al. Increased cocaine-induced conditioned place preference during periadolescence in maternally separated male BALB/c mice: the role of cortical BDNF, microRNA-212, and MeCP2. Psychopharmacology (Berl) 2016;233(17):3279–3288. doi: 10.1007/s00213-016-4373-z. [DOI] [PubMed] [Google Scholar]
  • 146.Solomon M.G., et al. Brain regional and temporal changes in BDNF mRNA and microRNA-206 expression in mice exposed to repeated cycles of chronic intermittent ethanol and forced swim stress. Neuroscience. 2019;406:617–625. doi: 10.1016/j.neuroscience.2019.02.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Fumagalli F., et al. Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Eur. Neuropsychopharmacol. 2009;19(6):402–408. doi: 10.1016/j.euroneuro.2009.01.003. [DOI] [PubMed] [Google Scholar]
  • 148.Graham D.L., et al. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat. Neurosci. 2007;10(8):1029–1037. doi: 10.1038/nn1929. [DOI] [PubMed] [Google Scholar]
  • 149.Rohleder N. Stress and inflammation - the need to address the gap in the transition between acute and chronic stress effects. Psychoneuroendocrinology. 2019;105:164–171. doi: 10.1016/j.psyneuen.2019.02.021. [DOI] [PubMed] [Google Scholar]
  • 150.Calcagni E., Elenkov I. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N. Y. Acad. Sci. 2006;1069:62–76. doi: 10.1196/annals.1351.006. [DOI] [PubMed] [Google Scholar]
  • 151.Frank M.G., et al. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 2010;24(1):19–30. doi: 10.1016/j.bbi.2009.07.008. [DOI] [PubMed] [Google Scholar]
  • 152.McGrath A.G., Briand L.A. A potential role for microglia in stress- and drug-induced plasticity in the nucleus accumbens: a mechanism for stress-induced vulnerability to substance use disorder. Neurosci. Biobehav. Rev. 2019;107:360–369. doi: 10.1016/j.neubiorev.2019.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Fox H.C., et al. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum. Psychopharmacol. 2012;27(2):156–166. doi: 10.1002/hup.1251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Goshen I., et al. The role of endogenous interleukin-1 in stress-induced adrenal activation and adrenalectomy-induced adrenocorticotropic hormone hypersecretion. Endocrinology. 2003;144(10):4453–4458. doi: 10.1210/en.2003-0338. [DOI] [PubMed] [Google Scholar]
  • 155.Bethin K.E., Vogt S.K., Muglia L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. U. S. A. 2000;97(16):9317–9322. doi: 10.1073/pnas.97.16.9317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Lewitus G.M., et al. An adaptive role of TNFalpha in the regulation of striatal synapses. J. Neurosci. 2014;34(18):6146–6155. doi: 10.1523/JNEUROSCI.3481-13.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 157.Schwarz J.M., Hutchinson M.R., Bilbo S.D. Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression. J. Neurosci. 2011;31(49):17835–17847. doi: 10.1523/JNEUROSCI.3297-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Hutchinson M.R., et al. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) Brain Behav. Immun. 2009;23(2):240–250. doi: 10.1016/j.bbi.2008.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Bland S.T., et al. The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release. Brain Behav. Immun. 2009;23(4):492–497. doi: 10.1016/j.bbi.2009.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160.Onaivi E.S., et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One. 2008;3(2):e1640. doi: 10.1371/journal.pone.0001640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Vranjkovic O., Gasser P.J. 2014. Stress-induced Cocaine Seeking Requires a Beta-2 Adrenergic Receptor-Regulated Pathway from the Ventral Bed Nucleus of the Stria Terminalis that Regulates CRF Actions in the Ventral Tegmental Area; pp. 12504–12514. 34(37) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162.Chen H., Fu Y., Sharp B.M. Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology. 2008;33(4):721–730. doi: 10.1038/sj.npp.1301466. [DOI] [PubMed] [Google Scholar]
  • 163.Fontaine H.M., et al. Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT(1B) receptors. Neuropsychopharmacology. 2022;47(4):891–901. doi: 10.1038/s41386-021-01178-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Razavinasab M., et al. Early environmental enrichment prevents cognitive impairments and developing addictive behaviours in a mouse model of prenatal psychological and physical stress. Int. J. Dev. Neurosci. 2022;82(1):72–84. doi: 10.1002/jdn.10161. [DOI] [PubMed] [Google Scholar]
  • 165.Calpe-López C., et al. Resilience to the effects of social stress on vulnerability to developing drug addiction. World J. Psychiatr. 2022;12(1):24–58. doi: 10.5498/wjp.v12.i1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available on request.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES